BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
1/13/2020 11:27:13 AM | Browse: 835 | Download: 1323
 |
Received |
|
2019-10-18 14:38 |
|
Peer-Review Started |
|
2019-10-18 14:39 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2019-11-22 03:33 |
|
Revised |
|
2019-12-06 11:46 |
|
Second Decision |
|
2019-12-19 04:00 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Company Editor-in-Chief |
|
2019-12-22 13:15 |
|
Articles in Press |
|
2019-12-22 13:15 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2019-12-29 03:06 |
|
Typeset the Manuscript |
|
2020-01-10 08:46 |
|
Publish the Manuscript Online |
|
2020-01-13 11:27 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Observational Study |
| Article Title |
Rifaximin improves survival in cirrhotic patients with refractory ascites: A real-world study
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Xin-Yue Lv, Hui-Guo Ding, Jun-Fu Zheng, Chun-Lei Fan and Lei Li |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| the State Key Projects Specialized on Infectious Diseases |
2017ZX10203202-004, 2017ZX10203202003008 |
| Beijing Natural Science Foundation-Beijing Municipal Committee of Education |
KZ201810025037 |
| Beijing high-level health technicians |
2013-03-073 |
| Beijing Municipal Administration of Hospitals' Ascent Plan |
DFL20151602 |
| The Digestive Medical Coordinated Development Centre of the Beijing Municipal Administration of Hospitals |
XXZ0303 |
|
| Corresponding Author |
Lei Li, MD, PhD, Associate Professor, Chief Physician, Department of Gastroenterology and Hepatology, Beijing You An Hospital, Capital Medical University, 8 Xi TouTiao, Youanmenwai, Fengtai District,, Beijing 100069, China. m13699119545@163.com |
| Key Words |
Rifaximin; Cirrhosis; Refractory ascites; Inflammatory factors; Gut microbiota; Metagenomics sequencing |
| Core Tip |
This study showed that the unabsorbed antibiotics, rifaximin, mitigates ascites and improves the survival of cirrhotic patients with refractory ascites and the possible mechanism is that rifaximin regulates the structure and function of intestinal bacteria, thus improving the systemic inflammatory state. |
| Publish Date |
2020-01-13 11:27 |
| Citation |
Lv XY, Ding HG, Zheng JF, Fan CL, Li L. Rifaximin improves survival in cirrhotic patients with refractory ascites: A real-world study. World J Gastroenterol 2020; 26(2): 199-218 |
| URL |
https://www.wjgnet.com/1007-9327/full/v26/i2/199.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v26.i2.199 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
